Pangaea Oncology, S.A. (PANG.MC)

EUR 1.68

(0.0%)

Net Income Summary of Pangaea Oncology, S.A.

  • Pangaea Oncology, S.A.'s latest annual net income in 2023 was -4.65 Million EUR , down -71.69% from previous year.
  • Pangaea Oncology, S.A.'s latest quarterly net income in 2023 FY was -4.65 Million EUR , down -71.69% from previous quarter.
  • Pangaea Oncology, S.A. reported an annual net income of -2.71 Million EUR in 2022, down -322.51% from previous year.
  • Pangaea Oncology, S.A. reported an annual net income of -641.9 Thousand EUR in 2021, up 64.23% from previous year.
  • Pangaea Oncology, S.A. reported a quarterly net income of -459.78 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
  • Pangaea Oncology, S.A. reported a quarterly net income of -1.86 Million EUR for 2023 Q3, down -306.37% from previous quarter.

Annual Net Income Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Net Income of Pangaea Oncology, S.A. (2023 - 2013)

Year Net Income Net Income Growth
2023 -4.65 Million EUR -71.69%
2022 -2.71 Million EUR -322.51%
2021 -641.9 Thousand EUR 64.23%
2020 -1.79 Million EUR 62.93%
2019 -4.84 Million EUR -286.39%
2018 -1.25 Million EUR 23.93%
2017 -1.64 Million EUR -177.01%
2016 -594.53 Thousand EUR -22.24%
2015 -486.35 Thousand EUR -147.65%
2014 -196.38 Thousand EUR -353.73%
2013 77.39 Thousand EUR 0.0%

Peer Net Income Comparison of Pangaea Oncology, S.A.

Name Net Income Net Income Difference
Clínica Baviera, S.A. 35.97 Million EUR 112.945%